There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DENTSPLY SIRONA (XRAY – Research Report) and GlycoMimetics (GLYC – Research Report) with bullish sentiments. DENTSPLY SIRONA (XRAY) In a report released today, Brandon Couillard from Jefferies maintained a Buy rating on DENTSPLY SIRONA, with a price target of $37.00. The company's shares closed last Friday at $31.13, close to its 52-week low of $26.48.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dentsply-sirona-xray-and-glycomimetics-glyc?utm_source=advfn.com&utm_medium=referral
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Jan 2023 até Fev 2023 Click aqui para mais gráficos DENTSPLY SIRONA.
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Fev 2022 até Fev 2023 Click aqui para mais gráficos DENTSPLY SIRONA.